Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Julphar
Fish and Richardson
Queensland Health
Daiichi Sankyo
Colorcon
Healthtrust
Teva
McKinsey
Medtronic
UBS

Generated: October 22, 2017

DrugPatentWatch Database Preview

SER-A-GEN Drug Profile

« Back to Dashboard

Which patents cover Ser-a-gen, and when can generic versions of Ser-a-gen launch?

Ser-a-gen is a drug marketed by Solvay and is included in one NDA.

The generic ingredient in SER-A-GEN is hydralazine hydrochloride; hydrochlorothiazide; reserpine. There are twenty drug master file entries for this compound. Additional details are available on the hydralazine hydrochloride; hydrochlorothiazide; reserpine profile page.

Summary for Tradename: SER-A-GEN

US Patents:0
Applicants:1
NDAs:1
Bulk Api Vendors: see list47
Clinical Trials: see list74
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:SER-A-GEN at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Solvay
SER-A-GEN
hydralazine hydrochloride; hydrochlorothiazide; reserpine
TABLET;ORAL087210-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Moodys
UBS
Colorcon
Fuji
Mallinckrodt
Fish and Richardson
Farmers Insurance
McKinsey
Chubb
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot